Last reviewed · How we verify

Estradiol followed by progesterone

US Department of Veterans Affairs · FDA-approved active Small molecule Quality 5/100

Estradiol followed by progesterone is a Small molecule drug developed by US Department of Veterans Affairs. It is currently FDA-approved.

At a glance

Generic nameEstradiol followed by progesterone
SponsorUS Department of Veterans Affairs
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Estradiol followed by progesterone

What is Estradiol followed by progesterone?

Estradiol followed by progesterone is a Small molecule drug developed by US Department of Veterans Affairs.

Who makes Estradiol followed by progesterone?

Estradiol followed by progesterone is developed and marketed by US Department of Veterans Affairs (see full US Department of Veterans Affairs pipeline at /company/us-department-of-veterans-affairs).

What development phase is Estradiol followed by progesterone in?

Estradiol followed by progesterone is FDA-approved (marketed).

Related